This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Esophageal manometry is a test used to measure the function of the muscles of the esophagus, the muscular tube that carries food from the mouth to the stomach. It is also used to evaluate symptoms such as chest pain, difficulty swallowing, and heartburn. The test is performed by inserting a thin, flexible tube with a pressure-sensing device through the nose and into the esophagus. The tube is then advanced to the lower esophageal sphincter (LES), a muscular valve that separates the stomach from the esophagus. Esophageal manometry measures the pressure and muscle contractions of the esophagus as it moves food and liquids from the mouth to the stomach. It can be helpful in diagnosing a variety of conditions, including gastroesophageal reflux disease (GERD), achalasia, and scleroderma. It can also help determine the cause of dysphagia, difficulty swallowing. Esophageal manometry is typically done in a hospital or outpatient setting. The procedure usually takes about 30 minutes. During the test, the patient is asked to swallow a liquid or a thin piece of food. This triggers a series of nerve impulses and muscle contractions that are measured by the tube. The data is then used to create a manometry chart, which shows the pressure and muscle contractions of the esophagus. Esophageal manometry is a safe, non-invasive test. The most common side effects are gagging and the feeling of a foreign object in the throat. In some cases, there may be some mild discomfort or a feeling of pressure in the chest.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States